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Materials and Methods
Cell Culture. The human foreskin fibroblast strain FS-4 was obtained from Dr. J. Vilcek (New York University School of Medicine, New York) ; procedures for its growth in cell culture and for the IFN -#2 mRNA induction experiments have been described (15, 17) .
RNA Blot-hybridization Analyses. Procedures for isolation of poly(A)' RNA from FS-4 cells (approximate RNA yield 1 Fag per T-175 culture), electrophoresis ofthe RNA in 1 agarose gels containing 10 mM methylmercury hydroxide, transfer to aminobenzyloxymethyl cellulose paper (ABM paper; Pharmacia Fine Chemicals, Piscataway, NJ), and hybridization with full-length human IFN-fl, and -N2 cDNA clones have been described (15, 17) .
Assayfor Antiviral Activity. These were carried out essentially as described by Sehgal et al. (17) . Briefly, FS-4 cells were seeded in 96-well microtiter plates in Eagle's MEM supplemented with 5% (vol/vol) heat-inactivated FCS (56°C for 0 .5 h; Gibco, Grand Island, NY) to produce confluent monolayers. 6-8 d later the culture medium was discarded and the monolayers were exposed to 100-,1 aliquots offresh medium containing serial two-fold dilutions of the test samples . After incubation for 24 h, the monolayers were challenged with vesicular stomatitis virus (VSV)' (Indiana strain, 10-100 plaque forming units [PFU] /well) such that it produced complete destruction of control FS-4 cell sheets 3-4 d after challenge . 4 d after addition of VSV, the cell monolayers were fixed with ethanol and stained using Gram's crystal violet. Antiviral assays were calibrated using appropriate human IFN-/4, standards.
Assay for Enhancement of B Cell Differentiation. The CESS line of human B lymphoblastoid cells (TIB190 ; American Type Culture Collection, Rockville, MD) was grown in RPMI 1640 medium (Flow Laboratories, McLean, VA) supplemented with 10% (vol/vol) heat-inactivated FCS (Hazelton Systems, Inc., Aberdeen, MD) and 2 mM glutamine (Gibco) . The ability of various dilutions of FS-4 cell culture medium to enhance differentiation of 10" CESS cells after 60 h of incubation in 0.2 ml of medium in 96-well microtiter plates (Linbro Chemical Co., Hamden, CT) was determined in triplicate using a reverse plaque-forming cell (PFC) hemolytic assay, which detects the ability ofindividual differentiated CESS cells to secrete human immunoglobulin IgG (18, (20) (21) (22) . This assay, which detects lysis of protein A-coupled sheep erythrocytes in the vicinity of each immunoglobulin-secreting CESS cell, has been described in detail elsewhere (18, (20) (21) (22) . It monitors the differentiation of CESS cells from an IgG-nonsecreting phenotype to an IgG-secreting phenotype .
Reagents. All LPS preparations, cycloheximide, and dexamethasone were purchased from Sigma Chemical Co., St. Louis, MO. The compounds H7 and H8 were purchased from Seikagaku America, St. Petersberg, FL. Recombinant E. coli-derived human IL-la (sp act 3 X 107 U/mg) was a gift from Hoffman-LaRoche, Nutley, NJ, and recombinant E. coli-derived human TNF (sp act 4 .8 X 107 U/mg) was a gift from The Suntory Institute for Biomedical Research, Osaka, Japan, and, recombinant E. coli-derived IFN-,B, was a gift from Triton Biosciences, Inc., Alameda, CA. Gram's crystal violet was purchased from Fisher Scientific, Orangeburg, NY; a-[ s2P]dCTP used for nick translation ofplasmid DNA was purchased from New England Nuclear, Boston, MA. Autoradiography was performed at -70°C using Kodak XAR-5 film and intensifying screens (Quanta III ; DuPont Co., Wilmington, DE).
Results and Discussion Antiviral Activity of Bacterial LPS in Human Fibroblasts . In the course of experiments to express human IFN-N2 in E. coli we observed that an aqueous extract of E. coli could itself induce an antiviral state in human fibroblasts (FS-4 strain) against VSV (Fig. 1) . LPS derived from E. coli also elicited an antiviral ' Abbreviations used in this paper: HSF, hepatocyte-stimulating factor; PFC, plaque-forming cell ; VSV, vesicular stomatitis virus. FIGURE 1 . Inhibition of the cytopathic effect of VSV in fibroblasts incubated with E. coliderived LPS. FS-4 cells were seeded in 96-well microtiter plates to produce confluent monolayers . 6 d later the culture medium was discarded and the monolayers were exposed to 100 ul aliquots of fresh medium containing serial twofold dilutions (from left to right in the figure) of a recombinant IFN-0, preparation (titer 100 IU/ml), a preparation of phenol-extracted LPS derived from E. coli serotype 0111 :114 (highest concentration tested was 1 ug/ml), or an extract of E. coli strain HB10I (prepared by sedimenting bacteria from a 5 ml log-phase culture, subjecting the pellet to a freeze-thaw cycle, followed by resuspension in 0.5 ml water, sonication, and Millipore filtration [0.22 ,um]). After incubation for 24 h, the monolayers were challenged with VSV. 4 d after addition of VSV, the cell monolayers were fixed with ethanol and stained using the crystal violet . Dark-stained monolayers are those that have been protected from virus-mediated cell killing . state ( Fig. 1 ). This represents a rediscovery of the antiviral effect of LPS in cell culture. Likar et al. (23) reported in 1959 that E. coli and Salmonella typhimurium endotoxin inhibited poliovirus replication in secondary monkey kidney cells . That a bacterial constituent can have an inhibitory effect on viral multiplication was first demonstrated with the capsular polysaccharide of Klebsiella pneumoniae and the pneumonia virus of mice and the mumps virus (24) (25) (26) . In the 1960s a number of reports documented the antiviral effects of constituents of Gramnegative as well as Gram-positive bacteria in cultures of fibroblasts or epithelial cells (27) (28) (29) (30) (31) (32) . As the inhibitory substances from the Gram-positive bacteria had a narrow range of antiviral activity (27) (28) (29) , it appeared unlikely that their action was mediated via the production of endogenous IFN. It is, however, of interest FIGURE 2. Induction of IFN-02 mRNA in fibroblasts by an extract of E. coli (a) or by E. coli-derived LPS (b). Confluent monolayers of FS-4 cells in T-175 flasks (one flask per group) were exposed for 6-7 h to a 1 :10 dilution of a pool of E . coli extracts prepared essentiallyas mentioned in Fig. 1 (sonication was omitted) or to LPS at different concentrations (E. coli, serotype 0111 :134). The E. coli extract was a pool of samples that displayed antiviral activity at dilutions in the range from 1:2 to 1 :8 . The levels of IFN-02 mRNA were monitored by agarose gel electrophoresis followed by blot hybridization using a fulllength human IFN-02 cDNA probe. that actinomycin D inhibited the development of the antiviral state elicited by an E. coli extract (32) .
Induction ofIFN-(32 mRNA by Bacterial LPS in Human Fibroblasts. We observed that the antiviral activity of LPS in FS-4 cells could be completely blocked by an anti-IFN-,B antiserum (not shown), thus implicating the induction of endogenous IFN-,B by LPS in the development of the antiviral state. Using blot-hybridization methods we determined that extracts of E. coli or LPS prepared from E. coli enhanced the levels of IFN-02 mRNA in FS-4 cells (Fig. 2) . It should be emphasized that LPS did not induce detectable levels of IFN-,E, mRNA (not shown) .
LPS enhances IFN-02 mRNA levels in FS-4 cells at concentrations as low as 0.3 ng/ml (Fig. 2B, lane 6) . The enhancement is near-maximal at an LPS concentration in the range 0.1-1 jAg/ml (Fig. 2B) . The enhancement is rapid; an increase is detected within 30 min after addition of LPS, and is near-maximal by 2-3 h (Fig. 3) . The increase is sustained at this high level for at least 20 h thereafter (not shown) .
The enhancement of IFN-02 gene expression in FS-4 cells by LPS is moderately inhibited by 50 jM H8, a preferential inhibitor of cAMP-and cGMP-dependent protein kinases compared with protein kinase C (33), but is strongly inhibited by 50 uM H7, an inhibitor of protein kinase C as well as of cyclic nucleotidedependent protein kinases (33) (Fig. 4A ). These observations are consistent with the possibility that LPS enhances IFN-02 gene expression in fibroblasts by activating the protein kinase C signal transduction pathway. Evidence has been obtained in some, but not all studies of the involvement of protein kinase C in the activation of resting murine B lymphocytes by LPS (34) (35) (36) . It is noteworthy that H7, but not H8, efficiently blocks IFN-02 gene expression in fibroblasts treated with IL-1 or TNF (Fig. 4B) (17) .
LPS increased the levels of IFN-02 mRNA in FS-4 cells in the presence of cycloheximide, indicating that new protein synthesis is not required for this induction (Fig. 5, lanes 1-4) . A combination of LPS and cycloheximide "superinduces" the expression of IFN -N2 mRNA (Fig. 4 , lane 4) (37, 38) . Of special interest is the fact that the induction of IFN-#2 mRNA by LPS is inhibited by dexamethasone (Fig. 5B, lanes 6-8) , a glucocorticoid that also inhibits the induction, in FS-4 cells, of IFN -02 mRNA by IL-1 and TNF (39) . Dexamethasone may affect a common element in the signal transduction pathways used by the three reagents. It has been suggested that dexamethasone inhibits some step proximal to the formation of second messengers through the agonist-induced hydrolysis of inositol phospholipids in LPS-stimulated murine B cells (40) . The enhancement of IFN-R2 mRNA levels in FS-4 cells is a property of several different LPS preparations . Chromatographically purified LPS derived from three different strains of E. coli, as well as LPS derived from a strain of S. typhimurium enhance IFN-R2 mRNA levels (Fig. 6) .
B Cell Differentiation Activity of Conditioned Medium from LPS-treated Fibroblast
Cultures . One of the immunologic consequences of IFN-#2 secreted by LPStreated fibroblasts is illustrated in Table 1 . FS-4 cells were treated with LPS for 6 h and then incubated in LPS-free medium for another 24 h . The culture PFC/culture when FS-4 cell culture medium was added to CESS cells at dilutions of.
Confluent monolayers of FS-4 cells in T-175 flasks containing 10 ml of spent medium were treated for 6 h with LPS at 1 or 0.1 wg/ml or with TNF (30 ng/ml) and cycloheximide (CHX, 50 ug/ml) . The cultures were then washed extensively with PBS and incubated in another 10 ml of spent medium per flask. Culture medium was harvested 24 h later, cell debris removed by centrifugation, and appropriate aliquots stored at -70°C . Theability of various dilutions of FS-4 cell culture medium to enhance differentiation of 10' CESS cells after 60 h of incubation in 0.2 ml of medium in 96-well microtiter plates was determined in triplicate using a reverse PFC hemolytic assay. As controls, S. aureus Cowan I antigen (0 .01%, vol/vol; Behring Diagnostics) or E. coli LPS (1 Ag/ml) was added directly to the CESS cells. Saturating amounts of B cell differentiation factor activity appear to be present in the 1 :8 dilution of the medium samples from induced FS-4 cell cultures; at the 1 :100 dilution a lesser amount of activity is observed. * Mean of six experiments. 1305 medium obtained from LPS-treated FS-4 cells was then tested for its ability to stimulate differentiation (immunoglobulin secretion) by an Epstein-Barr virustransformed human B cell line (CESS) (18, 19) . It is clear from Table I that LPStreated FS-4 cells produce a cytokine that increases the number of IgG-secreting CESS cells. Treatment of FS-4 cells with LPS or TNF at maximally effective concentrations yielded culture media that caused comparable increases in the number of IgG-secreting CESS cells (Table I) .
Fibroblasts are not the only kinds of cells that secrete IFN -N2 when exposed to LPS. It is known that human monocytes exposed to LPS secrete a protein called the hepatocyte-stimulating factor (HSF) that alters the expression of plasma protein genes in the liver (41) (42) (43) (44) (45) (46) (47) (48) (49) . For example, HSF decreases the synthesis of albumin and increases the synthesis of fibrinogen, haptoglobin, a2-macroglobulin, and C-reactive protein. The alterations in liver gene expression constitute the acute-phase response that occurs in acute bacterial or mycoplasma infections, and tissue damage and is elicited by HSF as well as IL-1 (41-49). However, HSF and IL-1 elicit qualitatively and quantitatively different responses in the expression of plasma protein genes (41) (42) (43) (44) (45) (46) (47) (48) (49) . It has recently been shown that HSF and IFN-(3 2 are the same molecule (10) . The acute-phase response mediated via the action of monocyte-derived IFN-,d2/HSF on the liver leads to systemic effects on the organism . In contrast, the fibroblast-derived IFN -02 may primarily give rise to effects of local importance . The ubiquitous fibroblasts play a key role in post-injury repair . LPS at concentrations in the range of 0.1 ng/ml to 5,ug/ml stimulates the proliferation of chick embryo, murine, bovine, and human fibroblasts (including FS-4 cells) (50) (51) (52) (53) . Production of IFN-02 by fibroblasts exposed to LPS is consistent with the hypothesis that IFN-02 is part of an homeostatic mechanism that regulates fibroblast proliferation (37, 38) . The IFN-02 secreted by LPS-stimulated fibroblasts may enhance in situ immunoglobulin secretion by B lymphocytes. Additional evidence for a role of IFN-02 in the pathophysiology of acute infections is provided by the findings of strong enhancement of IFN-02 gene expression in fibroblasts during virus infections (54 and D. C. Helfgott and P. B. Sehgal, unpublished data).
Summary
The human ,d2 interferon (IFN -R2) gene, a gene that also codes for B cell differentiation factor 2 (BSF-2), plasmacytoma/hybridoma growth factor (HGF), and hepatocyte-stimulating factor (HSF), is expressed in a variety of lymphoid and nonlymphoid tissues. Endotoxin, or bacterial lipopolysaccharide (LPS) preparations derived from the outer membrane of Escherichia coli or Salmonella typhimurium rapidly elevate IFN-02 mRNA level in human skin fibroblasts (FS-4 strain). E . coli-derived LPS enhances IFN -02 mRNA expression in FS-4 fibroblasts at a concentration as low as 0 .3 ng/ml ; this response is near-maximal in the range of 0.1-1 lig/ml LPS. The increase in IFN-02 mRNA level caused by LPS in FS-4 cells is detected within 30 min after addition of LPS, is sustained for at least 20 h thereafter, appears to involve the protein kinase C signal transduction pathway, does not require new protein synthesis, and is inhibited by dexamethasone in a dose-dependent fashion (in the range 10 -s -10-8 M) . Cultures of LPS-treated FS-4 cells exhibit an antiviral state against vesicular stomatitis virus, which can be prevented by anti-IFN-fl antiserum. Medium obtained from LPS-treated FS-4 cell cultures enhances the number of immunoglobulin-secreting cells in cultures of human B-lymphoblastoid (CESS) cells. Thus, LPS may trigger a number of host defense mechanisms in the course of infection due to Gram-negative bacteria by enhancing IFN-02 production by the ubiquitous fibroblast .
